EconPapers    
Economics at your fingertips  
 

BRIDELIA FERRUGINEA BARK: PHYTOCHEMICAL ANALYSIS AND BIOACTIVITY ASSESSMENT FOR POTENTIAL THERAPEUTIC APPLICATIONS

Olugbenga David Oloruntola (), Simeon Olugbenga Ayodele, Ojurereoluwa Adebimpe Ayodele, Emmanuel Kehinde Asaniyan, Olufemi Emmanuel Adeniji and Fehintoluwa Stellamaris Oladebeye
Additional contact information
Olugbenga David Oloruntola: Department of Animal Science, Adekunle Ajasin University, Akungba Akoko, Nigeria
Simeon Olugbenga Ayodele: Department of Agricultural Technology, Federal Polytechnic, Ado Ekiti, Nigeria
Ojurereoluwa Adebimpe Ayodele: Department of Animal Science, Adekunle Ajasin University, Akungba Akoko, Nigeria
Emmanuel Kehinde Asaniyan: Department of Animal Production and Health, Olusegun Agagu University of Science and Technology, Okiti Pupa, Nigeria
Olufemi Emmanuel Adeniji: Department of Animal Science, Adekunle Ajasin University, Akungba Akoko, Nigeria
Fehintoluwa Stellamaris Oladebeye: Department of Animal Science, Adekunle Ajasin University, Akungba Akoko, Nigeria

Science Heritage Journal (GWS), 2024, vol. 8, issue 2, 88-93

Abstract: Bridelia ferruguinea bark is investigated for its phytochemical composition and bioactivity to explore its therapeutic potential. The phytochemical analysis reveals significant quantities of alkaloids (62.95 mg/g), saponins (64.31 mg/g), flavonoids (100.19 mg/g), tannins (78.08 mg/g), and phenols (253.62 mg/g). The nitrogen-free extract dominates at 53.23%, followed by crude fiber at 24.44%. Additionally, the moisture, crude protein, crude fat, and ash content in Bridelia ferruguinea bark powder are reported at 7.63%, 2.15%, 8.72%, and 3.83%, respectively. Assessment of bioactivity indicates a lipid inhibition percentage of 23.88% and a vitamin C content of 55.97%. Moreover, the bark exhibits Fe chelation (13.44%) and DPPH radical scavenging activity (83.54%). Furthermore, it demonstrates inhibition of albumin denaturation (62.71%) and antiproteinase activity (69.534%). Importantly, it shows promising α-amylase inhibition (37.60%) and α-glucosidase inhibition (58.07%). These diverse bioactivities suggest potential applications in pharmaceuticals and nutraceuticals, warranting further studies for formulation development targeting both human and animal health. Bridelia ferruguinea bark emerges as a valuable natural resource with multifaceted therapeutic prospects, inviting extensive exploration for practical utilization.

Keywords: Bridelia ferruguinea; Phytochemical analysis; Bioactivity assessment; Therapeutic potential; Pharmaceutical and nutraceutical applications. (search for similar items in EconPapers)
Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://jscienceheritage.com/archives/2gws2024/2gws2024-88-93.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:zib:zbngws:v:8:y:2024:i:2:p:88-93

DOI: 10.26480/gws.02.2024.88.93

Access Statistics for this article

Science Heritage Journal (GWS) is currently edited by Professor Dr. Ahmed Jalal Khan Chowdhury

More articles in Science Heritage Journal (GWS) from Zibeline International Publishing
Bibliographic data for series maintained by Zibeline International Publishing ( this e-mail address is bad, please contact ).

 
Page updated 2025-05-31
Handle: RePEc:zib:zbngws:v:8:y:2024:i:2:p:88-93